Results

Total Results: 110 records

Showing results for "end stage renal".

  1. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication
    March 15, 2007 - At each screening stage, 2 members of the review team selected articles for inclusion after an initial … We sought existing systematic reviews to address the gastrointestinal, cardiovascular, and renal harms … The risks for hypertension and renal toxicity may also be elevated with COX-2 inhibitors and are reported … use; ASA, .162.5 mg/d or 325 mg every 2 days; FAP; HNPCC; IBD; invasive cancer; colonic resection; renal … Notes: a ASA = acetylsalicylic acid; BID = twice daily; COX-2 = cyclooxygenase-2; CRF = chronic renal
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
    March 01, 2007 - At each screening stage, 2 members of the review team selected articles for inclusion after an initial … We sought existing systematic reviews to address the gastrointestinal, cardiovascular, and renal harms … The risks for hypertension and renal toxicity may also be elevated with COX-2 inhibitors and are reported … Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized … use; ASA, �162.5 mg/d or 325 mg every 2 days; FAP; HNPCC; IBD; invasive cancer; colonic resection; renal
  3. www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/hepatitis-b-virus-infection-screening
    December 15, 2020 - hepatitis B are unaware of their infection, 3 and many remain asymptomatic until onset of cirrhosis or end-stage … Most studies adjusted for patient age, sex, and stage of fibrosis; some also adjusted for level of HBV … trials; RR, 0.92 [95% CI, 0.45-1.85]), any adverse event (5 trials; RR, 1.01 [95% CI, 0.90-1.11]), renal … therapies (including recently approved tenofovir alafenamide) on long-term health outcomes of cirrhosis, end-stage
  4. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
    March 15, 2007 - At each screening stage, 2 members of the review team selected articles for inclusion after an initial … We sought existing systematic reviews to address the gastrointestinal, cardiovascular, and renal harms … The risks for hypertension and renal toxicity may also be elevated with COX-2 inhibitors and are reported … use; ASA, .162.5 mg/d or 325 mg every 2 days; FAP; HNPCC; IBD; invasive cancer; colonic resection; renal … Notes: a ASA = acetylsalicylic acid; BID = twice daily; COX-2 = cyclooxygenase-2; CRF = chronic renal
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/xbYLYNJZ5zJXj-W4DNyxyb
    June 20, 2019 - Ann Intern Med. 2004;140:W9-W24. www.annals.org For author affiliations, see end of text. … 1982 (55) Diagnostic use in symptomatic patients Fadayomi et al., 1987 (56) Unclear ascertainment of end … men Clinical evidence of CHD, use of lipid-lowering agents, diabetes mellitus for �5 y, retinopathy, renal … � SD, 56 � 11 y; 70% men Age � 30 y, symptomatic heart failure, use of digoxin, valvular disease, end-stagerenal disease, pacer, atrial fibrillation, heart block, frequent ventricular ectopic arrhythmia at rest
  6. www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/asymptomatic-bacteriuria-in-adults-screening
    September 24, 2019 - It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stagerenal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized … Subclinical renal infection and prematurity. Med J Aust . 1969;2(12):596-600. 21. 
  7. www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening
    December 15, 2020 - hepatitis B are unaware of their infection, 3 and many remain asymptomatic until onset of cirrhosis or end-stage … Most studies adjusted for patient age, sex, and stage of fibrosis; some also adjusted for level of HBV … trials; RR, 0.92 [95% CI, 0.45-1.85]), any adverse event (5 trials; RR, 1.01 [95% CI, 0.90-1.11]), renal … therapies (including recently approved tenofovir alafenamide) on long-term health outcomes of cirrhosis, end-stage
  8. www.uspreventiveservicestaskforce.org/uspstf/document/exercise-tolerance-testing-to-screen-for-coronary-heart-dise/coronary-heart-disease-electrocardiography-screening-2004
    February 03, 2004 - arrhythmia, dissection of the aorta and coronary artery, retroperitoneal bleeding, femoral artery aneurysm, renal … Diagnostic use in symptomatic patients Fadayomi et al., 1987 56 Unclear ascertainment of end … Clinical evidence of CHD, use of lipid lowering agents, diabetes mellitus for less than 5 y, retinopathy, renal … ±SD: 56 ±11 y 70% men Age <30 y, symptomatic heart failure, use of digoxin, valvular disease, end-stagerenal disease, pacer, atrial fibrillation, heart block, frequent ventricular ectopic arrhythmia at rest
  9. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary52/vitamin-d-and-calcium-to-prevent-fractures-preventive-medication-2013
    December 10, 2011 - One RCT showed adverse outcomes associated with supplementation, including increased risk for renal and … We recorded whether the cancer or fracture outcomes were primary or secondary end points in the original … Cancer outcomes were secondary end points in all 3 RCTs. … Fracture outcomes were primary end points in 13 (81%) of the 16 RCTs. … Others have suspected that the adverse outcomes of renal and urinary stones were associated with excess
  10. www.uspreventiveservicestaskforce.org/uspstf/recommendation/asymptomatic-bacteriuria-in-adults-screening
    September 24, 2019 - It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stagerenal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized … Subclinical renal infection and prematurity. Med J Aust . 1969;2(12):596-600. 21. 
  11. www.uspreventiveservicestaskforce.org/home/getfilebytoken/6L2obA88s86MoZDbWtMPTU
    December 01, 2011 - One RCT showed adverse outcomes associated with supplementa- tion, including increased risk for renal … Ann Intern Med. 2011;155:827-838. www.annals.org For author affiliations, see end of text. … We recorded whether the cancer or fracture out- comes were primary or secondary end points in the original … Cancer out- comes were secondary end points in all 3 RCTs. … Fracture outcomes were pri- mary end points in 13 (81%) of the 16 RCTs.
  12. www.uspreventiveservicestaskforce.org/home/getfilebytoken/3R9N4ojm9Sk7qk8ybD3LU6
    October 11, 2019 - It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stagerenal dis- ease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized … Subclinical renal infection and prematurity. Med J Aust. 1969;2(12):596-600. 21.
  13. www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening-january-2016
    January 11, 2016 - include (but are not limited to) AIDS, chronic obstructive pulmonary disease, liver disease, chronic renal … Information about morbidity or mortality end points is not available, so whether these women ultimately … the 19% estimate derived from the trials that did not have screening in their control groups at the end … Based on data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) … Based on data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER)
  14. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hypertension-in-adults-screening
    April 27, 2021 - mortality, cardiovascular disease events, symptomatic peripheral artery disease, vascular dementia, end-stagerenal disease, and quality of life. … Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic … BP indicates blood pressure; CVD, cardiovascular disease; ESRD, end-stage renal disease; PAD, peripheral
  15. www.uspreventiveservicestaskforce.org/home/getfilebytoken/pth_4-Mnau_pZubaefDvUk
    January 01, 2020 - Ann Intern Med. 2016;164:279-296. doi:10.7326/M15-2886 www.annals.org For author affiliation, see end … Based on data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) … include (but are not limited to) AIDS, chronic obstructive pulmonary disease, liver disease, chronic renal … Information about morbid- ity or mortality end points is not available, so whether these women ultimately … the 19% estimate de- rived from the trials that did not have screening in their control groups at the end
  16. www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-abnormal-blood-glucose-and-type-2-diabetes-october-2015
    October 26, 2015 - cardiovascular mortality and morbidity and may also result in other complications, such as vision loss, renal … Diabetes is the leading cause of kidney failure, accounting for more than 44% of new cases of end-stagerenal disease in 2011. … Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose
  17. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary16/blood-pressure-in-children-and-adolescents-hypertension-screening-october-2013
    February 15, 2013 - Screening children and adolescents for elevated blood pressure could identify hypertension at an early stage … 53 , 54 , 57-59 reported the percentage of participants achieving target blood pressure at the end … However, 26% to 47% of children in the placebo groups also achieved normal blood pressure at the end … assesses the effectiveness of interventions on final health outcomes in adulthood represented at the end … including C-reactive protein Body changes in weight or BMI 1 and 7: Severe visual impairment Stage
  18. www.uspreventiveservicestaskforce.org/uspstf/recommendation/abnormal-blood-glucose-type-2-diabetes-mellitus-screening-1996
    January 01, 1996 - 120,000 annual nontraumatic amputations in the U.S. 6 Diabetic nephropathy is now the leading cause of end-stagerenal disease in the U.S. 7 and, if current trends continue, will soon account for 50% of all patients … with renal failure. 8 Diabetes is the leading cause of blindness in adults ages 20-74 and accounts … Onset and progression of diabetic glomerulosclerosis: a prospective study based on serial renal biopsies … Glucose control and the renal and retinal complications of insulin-dependent diabetes mellitus.
  19. www.uspreventiveservicestaskforce.org/uspstf/recommendation/diabetes-mellitus-screening-1996
    January 01, 1996 - 120,000 annual nontraumatic amputations in the U.S. 6 Diabetic nephropathy is now the leading cause of end-stagerenal disease in the U.S. 7 and, if current trends continue, will soon account for 50% of all patients … with renal failure. 8 Diabetes is the leading cause of blindness in adults ages 20-74 and accounts … Onset and progression of diabetic glomerulosclerosis: a prospective study based on serial renal biopsies … Glucose control and the renal and retinal complications of insulin-dependent diabetes mellitus.
  20. www.uspreventiveservicestaskforce.org/home/getfilebytoken/ykjVKfmV5Jf8bL3rBx8BP7
    December 01, 2015 - Ann Intern Med. 2015;163:861-868. doi:10.7326/M15-2345 www.annals.org For author affiliation, see end … - vascular mortality and morbidity and may also result in other complications, such as vision loss, renal … Diabetes is the leading cause of kid- ney failure, accounting for more than 44% of new cases of end-stagerenal disease in 2011. … Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: